TBPMQ — Tetra Bio Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Tetra Bio Pharma, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

	2017 November 30th	2018 November 30th	2019 November 30th	2020 November 30th	2021 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-6.7	-7.85	-14.2	-21.2	-52.2
Depreciation
Amortisation
Non-Cash Items	2.6	-2.8	-3.12	-0.699	27.2
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.2	1.14	-0.008	2.18	-0.431
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-3.89	-9.51	-17.3	-19.6	-25.3
Capital Expenditures	-0.75	—	-0.255	-2.16	-1.15
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	-2.13	-3.43	-1.26	-0.966
Acquisition of Business
Sale of Business
Purchase of Investments
Cash from Investing Activities	-0.75	-2.13	-3.69	-3.42	-2.12
Financing Cash Flow Items	-0.007	-1.73	1.12	-3.52	-2.67
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	5.62	23	9.73	23.5	29.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.974	11.4	-11.3	0.463	2.39